We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.37B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+8.57%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.59%
AUM
$3.57B
AUM Growth
-$631M
(-15%)
Cap. Flow
-$878M
Cap. Flow
% of AUM
-24.58%
Top 10 Holdings %
Top 10 Hldgs %
58.69%
Holding
443
New
117
Increased
49
Reduced
81
Closed
96
Top Buys
| 1 |
SKX
Skechers
SKX
|
+$207M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$176M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$167M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
+$122M |
| 5 |
INFA
Informatica
INFA
|
+$93.8M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$408M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$408M |
| 3 |
HES
Hess
HES
|
+$251M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$195M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$137M |
Sector Composition
| 1 | Healthcare | 20.4% |
| 2 | Technology | 14.74% |
| 3 | Consumer Staples | 11.33% |
| 4 | Energy | 10.18% |
| 5 | Consumer Discretionary | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$785B
| $628K | 0.02% |
190,500
+105,500
| +124% | +$60.3M |
|
252
BridgeBio Pharma
BBIO
$16.2B
| $595K | 0.02% |
13,771
-11,721
| -46% | -$426K |
|
253
UWM Holdings
UWMC
$699M
| $592K | 0.02% |
143,000
| – | – |
|
254
Treace Medical Concepts
TMCI
$300M
| $590K | 0.02% |
100,317
-47,378
| -32% | -$309K |
|
|
VISN
255
CALL
Vistance Networks Inc
VISN
$2.76B
| $578K | 0.02% |
550,000
+100,000
| +22% | +$523K |
|
|
CEPT
256
DELISTED
Cantor Equity Partners II
CEPT
| $552K | 0.02% |
+50,000
| New | +$565K |
|
257
Nuvation Bio
NUVB
$2.01B
| $551K | 0.02% |
282,464
-309,655
| -52% | -$645K |
|
|
SBXD
258
SilverBox Corp IV
SBXD
| $548K | 0.02% |
50,000
-192,175
| -79% | -$2.01M |
|
259
Mobileye
MBLY
$7.68B
| $539K | 0.02% |
+30,000
| New | +$458K |
|
260
Neurogene
NGNE
$762M
| $520K | 0.01% |
34,761
-21,254
| -38% | -$334K |
|
261
Keros Therapeutics
KROS
$214M
| $506K | 0.01% |
37,891
-77,627
| -67% | -$1.05M |
|
262
Oric Pharmaceuticals
ORIC
$1.12B
| $497K | 0.01% |
49,000
+1,358
| +3% | +$9.12K |
|
263
Schrodinger
SDGR
$1.17B
| $490K | 0.01% |
24,358
-34,685
| -59% | -$792K |
|
264
PUT
MGM Resorts International
MGM
$11.9B
| $452K | 0.01% |
82,600
| – | – |
|
265
Tarsus Pharmaceuticals
TARS
$2.56B
| $446K | 0.01% |
+11,000
| New | +$495K |
|
266
Relay Therapeutics
RLAY
$4.39B
| $440K | 0.01% |
127,036
-255,864
| -67% | -$761K |
|
267
Arcus Biosciences
RCUS
$3.48B
| $431K | 0.01% |
52,975
-75,713
| -59% | -$647K |
|
268
PUT
Charter Communications
CHTR
$16.2B
| $383K | 0.01% |
20,500
| – | – |
|
269
Arvinas
ARVN
$525M
| $368K | 0.01% |
+50,000
| New | +$368K |
|
270
PUT
Herbalife
HLF
$1.3B
| $354K | 0.01% |
82,400
| – | – |
|
271
CALL
Shift4
FOUR
$4.06B
| $354K | 0.01% |
+35,000
| New | +$3.05M |
|
272
Sabre
SABR
$692M
| $348K | 0.01% |
+110,000
| New | +$282K |
|
273
CALL
Marvell Technology
MRVL
$177B
| $341K | 0.01% |
+75,000
| New | +$4.68M |
|
274
CALL
Replimune Group
REPL
$794M
| $308K | 0.01% |
+169,000
| New | +$1.47M |
|
275
PUT
Tesla
TSLA
$1.47T
| $289K | 0.01% |
12,500
| – | – |
|
Similar funds
FNBT
SAG
ACI
APSPRSPT
TCOV
LCM
RCM
RC